The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists not only improve metabolic abnormalities of diabetes and consequent diabetic nephropathy, but they also protect against nondiabetic chronic kidney disease in experimental models. Here, we found that the PPAR-gamma agonist pioglitazone protected against renal injury in aging; it reduced proteinuria, improved GFR, decreased sclerosis, and alleviated cell senescence. Increased local expression of PPAR-gamma paralleled these changes. Underlying mechanisms included increased expression of klotho, decreased systemic and renal oxidative stress, and decreased mitochondrial injury. Pioglitazone also regulated p66(Shc) phosphorylation, which integrates many signaling pathways that affect mitochondrial function and longevity, by reducing protein kinase C-beta. These results suggest that PPAR-gamma agonists may benefit aging-related renal injury by improving mitochondrial function.

[1]  K. Nair,et al.  Mitochondrial longevity pathways. , 2011, Biochimica et biophysica acta.

[2]  Jing Wu,et al.  Klotho is a target gene of PPAR-gamma. , 2008, Kidney international.

[3]  L. Franco,et al.  Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[4]  R. Wada,et al.  Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated‐γ‐ligand, in insulin‐deficient diabetic rats , 2007, Journal of neurochemistry.

[5]  Douglas A Rahn,et al.  The Thiazolidinedione Pioglitazone Alters Mitochondrial Function in Human Neuron-Like Cells , 2007, Molecular Pharmacology.

[6]  F. Turturro,et al.  Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines. , 2007, American journal of physiology. Cell physiology.

[7]  S. Minucci,et al.  Protein Kinase C ß and Prolyl Isomerase 1 Regulate Mitochondrial Effects of the Life-Span Determinant p66Shc , 2007, Science.

[8]  T. Prolla,et al.  The Role of Mitochondrial DNA Mutations in Mammalian Aging , 2007, PLoS genetics.

[9]  Li-jun Ma,et al.  Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. , 2006, Kidney international.

[10]  R. Balaban,et al.  The Mammalian Longevity-associated Gene Product p66shc Regulates Mitochondrial Metabolism* , 2006, Journal of Biological Chemistry.

[11]  P. Ye,et al.  Effect of Aging on the Expression of Peroxisome Proliferator-Activated Receptor γ and the Possible Relation to Insulin Resistance , 2006, Gerontology.

[12]  R. Medcalf,et al.  Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation. , 2005, Biochemical and biophysical research communications.

[13]  S. Minucci,et al.  Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial Apoptosis , 2005, Cell.

[14]  D. Feinstein,et al.  Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? , 2005, Biochemical pharmacology.

[15]  T. D. Pugh,et al.  Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging , 2005, Science.

[16]  K. Griendling,et al.  Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. , 2005, American journal of physiology. Cell physiology.

[17]  A. Minagar,et al.  Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α , 2005, BMC Physiology.

[18]  H. Chung,et al.  Modulation of PPAR in aging, inflammation, and calorie restriction. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  C. Franceschi,et al.  Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)γ-2 with longevity , 2004, Experimental Gerontology.

[20]  J. Gamble,et al.  PPARγ Agonists Ameliorate Endothelial Cell Activation via Inhibition of Diacylglycerol–Protein Kinase C Signaling Pathway: Role of Diacylglycerol Kinase , 2004, Circulation research.

[21]  D. L. Le Couteur,et al.  Aging Biology and Geriatric Clinical Pharmacology , 2004, Pharmacological Reviews.

[22]  S. Jimi,et al.  Cadmium‐Induced Nephropathy in Rats Is Mediated by Expression of Senescence‐Associated Beta‐Galactosidase and Accumulation of Mitochondrial DNA Deletion , 2004, Annals of the New York Academy of Sciences.

[23]  A. Gumieniczek.  Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits. , 2003, Life sciences.

[24]  F. Domann,et al.  Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. , 2002, Molecular endocrinology.

[25]  R. Scarpulla.  Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. , 2002, Gene.

[26]  M. Rigoulet,et al.  Aging and oxidative stress: studies of some genes involved both in aging and in response to oxidative stress. , 2001, Respiration physiology.

[27]  C. Marcantoni,et al.  Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. , 2001, Kidney international.

[28]  M. Andreucci,et al.  Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. , 2001, Kidney international.

[29]  A. Melk,et al.  Cell senescence and its implications for nephrology. , 2001, Journal of the American Society of Nephrology : JASN.

[30]  C. Marcantoni,et al.  Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. , 2000, Kidney international.

[31]  K. Hotta,et al.  Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[32]  Margaret S. Wu,et al.  Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. , 1998, Endocrinology.

[33]  L. Beck,et al.  Changes in renal function with aging. , 1998, Clinics in geriatric medicine.

[34]  M. A. Mahgoub,et al.  Diabetes mellitus and cardiac function , 1998, Molecular and Cellular Biochemistry.

[35]  W. Wilkison,et al.  Thiazolidinedione Exposure Increases the Expression of Uncoupling Protein 1 in Cultured Human Preadipocytes , 1998, Diabetes.

[36]  J. Cadet,et al.  Artifacts associated with the measurement of oxidized DNA bases. , 1997, Environmental health perspectives.

[37]  C. Richter,et al.  Quantification of wild-type mitochondrial DNA and its 4.8-kb deletion in rat organs. , 1997, Biochemical and biophysical research communications.

[38]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Taketomi,et al.  Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. , 1990, Arzneimittel-Forschung.

[40]  P. Wasserman,et al.  Changes in sizes and distensibility of the aging kidney. , 1981, The British journal of radiology.

[41]  T. Sugimoto,et al.  Peroxisome proliferator-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells , 2004 .

[42]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  T. Awata,et al.  The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells , 2001 .

[44]  J. Knight,et al.  The biochemistry of aging. , 2000, Advances in clinical chemistry.